
Telura 300 / 300 / 600mg Tablet
Salt Composition: Lamivudine (300mg) + Tenofovir disoproxil fumarate (300mg) + Efavirenz (600mg)
Expiry Date: 01/2028
Inclusive of all taxes
30 tablet
About The Product
HIV
Telura 300 / 300 / 600mg Tablet is a combination of three antiretroviral medications. It is used for the treatment of HIV (human immunodeficiency virus) infection. This medication belongs to a class of medication known as nucleoside reverse transcriptase inhibitors (NRTIs). Telura tablet boosts your immune system to fight against infection and prevents the virus from multiplying. It is important to take this medicine as prescribed by your healthcare provider. It is advisable not to change your regular dosing schedule without taking suggestions from your doctor.
Side Effects
- Telura 300 / 300 / 600mg Tablet shows some side effects.
- Some of the mild ones do not need any medical attention, and they go away as the body adapts to the medicine.
- It is important to consult your doctor if they persist for a longer time and are deteriorating your health.
- Common side effects include: Headache Fever Chills Loss of strength Fatigue Sore throat Unusual weakness Blurred vision Indigestion Constipation Redness of skin Abdominal pain Heartburn Inform your doctor immediately if you experience any persistent or unusual side effects.
How To Use
- The doctor determines the dosage and duration of treatment with Telura 300 / 300 / 600mg Tablet as per the patient's health condition.
- This medicine should be taken orally at the same time every day.
- Take it as a whole and don't crush or chew the medicine.
- This tablet should be taken without food.
- It is advised to take this medicine after consulting your healthcare expert.
Safety Advice
Missed Doses
- It is advisable not to miss a dose.
- If you miss a scheduled dose of Telura tablets, contact your doctor immediately.
FAQs
This is an antiviral medication that prevents the human immunodeficiency virus (HIV) from multiplying in your body.
Telura tablet also helps to delay the production of HIV infection and improve the quality of life.
Reference
1. Frampton, J.
E., & Croom, K. F.
(2006). Efavirenz/emtricitabine/tenofovir disoproxil fumarate: triple combination tablet.
Drugs, 66(11), 1501-1512. 2.
Kearney, B. P., Flaherty, J.
F., & Shah, J. (2004).
Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics. Clinical pharmacokinetics, 43(9), 595-612.
3. Gallant, J.
E., DeJesus, E., Arribas, J. R., Pozniak, A.
L., Gazzard, B., Campo, R. E., ... & Cheng, A.
K. (2006).
Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. New England Journal of Medicine, 354(3), 251-260.
4. Dravid, A., Betha, T.
P., Sharma, A. K., Gawali, R., Mahajan, U., Kulkarni, M., ... & Rathod, N.
(2020). Efficacy and safety of a single‐tablet regimen containing tenofovir disoproxil fumarate 300 mg, lamivudine 300 mg and efavirenz 400 mg as a switch strategy in virologically suppressed HIV‐1‐infected subjects on nonnucleoside reverse transcriptase inhibitor‐containing first‐line antiretroviral therapy in Pune, India.
HIV medicine, 21(9), 578-587. 5.
SANKARAIAH, J., SHARMA, N., & NAIM, M. J.
(2022). Formulation And Development Of Fixed-Dose Combination Of Bi-Layer Tablets Of Efavirenz, Lamivudine And Tenofovir Disoproxil Fumarate Tablets 600 Mg/300 Mg/300 Mg.
Int J App Pharm, 14(1), 185-197.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
.jpeg%3FupdatedAt%3D1763121181831&w=128&q=75)
